Alembic Pharma Secures USFDA Approval for Generic Methotrexate Injection
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic Methotrexate Injection USP, a product used in the treatment of several cancers as well as serious autoimmune conditions.